Physician

German G Kamalov, MD

According to 2025 Medicare claims, German Kamalov, MD (NPI: 1225259385) practices cardiology in the St. Joseph, MO-KS market, with the plurality of this provider's patient population coming from Buchanan, MO. This provider's primary affiliated billing organization is HEARTLAND REGIONAL MEDICAL CENTER (NPI: 1538200357; TIN: 440545289) and primary practice location at 64506-3488. Kamalov is affiliated with the Aledade 98 MO MSSP Enhanced (ACO ID: A4998), participating under the MSSP model.

Kamalov's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,097 traditional Medicare patients, billed 3,399 HCPCS/CPT codes, and received $188,932 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,177 prescription claims across 577 beneficiaries totaling $350,749 in drug costs, led by Xarelto (Rivaroxaban). DME data shows 44 claims. Open Payments data shows 30 records totaling $1,443. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $47,775 and ending at $350,749. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $40,662 to $5,952.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	340	1,403	$149,838
2016	562	2,534	$233,455
2017	921	3,880	$267,074
2018	815	3,809	$228,566
2019	866	4,123	$226,991
2020	1,040	2,767	$170,586
2021	1,033	3,275	$186,031
2022	963	3,516	$208,102
2023	938	3,049	$181,513
2024	1,097	3,399	$188,932

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	112	644	$47,775
2016	216	1,387	$110,215
2017	301	2,521	$246,753
2018	354	3,359	$356,404
2019	396	3,914	$457,926
2020	436	3,631	$477,764
2021	390	2,036	$187,482
2022	420	2,465	$227,195
2023	487	2,816	$316,440
2024	577	3,177	$350,749

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	19	$40,662
2018	N/R	16	$32,632
2019	N/R	14	$30,688
2020	N/R	N/R	N/R
2021	N/R	33	$2,494
2022	N/R	71	$41,657
2023	N/R	69	$5,256
2024	N/R	44	$3,008

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	192	215	$67
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	211	216	$45
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	294	335	$42
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	237	546	$18
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	128	137	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	90	6,257	$114,356
Eliquis	Apixaban	126	5,832	$112,727
Entresto	Sacubitril/Valsartan	35	1,830	$41,063
Dofetilide	Dofetilide	41	2,308	$8,760
Flecainide Acetate	Flecainide Acetate	232	13,660	$8,469

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0470	Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)	Y	N/R	15	$1,699
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	14	$969
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	15	$340

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	30	$1,443	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for German G. Kamalov, MD?

Tedicare shows public-source Medicare data for German G. Kamalov, MD (NPI 1225259385), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does German G. Kamalov, MD have ACO affiliation data?

German G. Kamalov, MD is shown with ACO affiliation data for Aledade 98 MO MSSP Enhanced (MSSP, ACO ID A4998).

What billing organization is linked to German G. Kamalov, MD?

German G. Kamalov, MD is linked to HEARTLAND REGIONAL MEDICAL CENTER (billing NPI 1538200357) in the available physician profile data.

Does German G. Kamalov, MD have Open Payments data?

German G. Kamalov, MD has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.